These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10449305)

  • 1. Atorvastatin for protease inhibitor-related hyperlipidaemia.
    Murillas J; Martín T; Ramos A; Portero JL
    AIDS; 1999 Jul; 13(11):1424-5. PubMed ID: 10449305
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.
    Baldini F; Di Giambenedetto S; Cingolani A; Murri R; Ammassari A; De Luca A
    AIDS; 2000 Jul; 14(11):1660-2. PubMed ID: 10983656
    [No Abstract]   [Full Text] [Related]  

  • 3. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities.
    Henry K; Melroe H; Huebesch J; Hermundson J; Simpson J
    Lancet; 1998 Sep; 352(9133):1031-2. PubMed ID: 9759748
    [No Abstract]   [Full Text] [Related]  

  • 4. Atorvastatin: in the management of hyperlipidaemia.
    Ray SK; Rege NN
    J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482
    [No Abstract]   [Full Text] [Related]  

  • 5. Atorvastatin and low-density lipoprotein subfractions profile in mixed hyperlipidaemia: a contributory effect of reduced hepatic lipase activity?
    Heller F; Descamps O; Hondekijn JC; Desager JP
    Ann Clin Biochem; 1999 Nov; 36 ( Pt 6)():788-9. PubMed ID: 10586326
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated lipoprotein(a) with statin therapy.
    Spielberg T
    Am J Cardiol; 2000 May; 85(9):1162. PubMed ID: 10896622
    [No Abstract]   [Full Text] [Related]  

  • 7. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
    Manfredi R; Chiodo F
    J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible fatal interaction between protease inhibitors and methamphetamine.
    Hales G; Roth N; Smith D
    Antivir Ther; 2000 Mar; 5(1):19. PubMed ID: 10846588
    [No Abstract]   [Full Text] [Related]  

  • 9. Atorvastatin in the management of an index patient with complete hepatic lipase deficiency.
    Hegele RA; Little JA; Connelly PW
    Atherosclerosis; 1999 Mar; 143(1):219-22. PubMed ID: 10208500
    [No Abstract]   [Full Text] [Related]  

  • 10. Atorvastatin: a new agent for hyperlipidemia.
    Kupecz D
    Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
    [No Abstract]   [Full Text] [Related]  

  • 11. Indications and outcome of treatment of hyperlipidemia in pediatric allograft recipients.
    Silverstein DM
    Pediatr Transplant; 2003 Feb; 7(1):7-10. PubMed ID: 12581321
    [No Abstract]   [Full Text] [Related]  

  • 12. Liptruzet: a combination of ezetimibe and atorvastatin.
    Med Lett Drugs Ther; 2013 Jun; 55(1419):49-50. PubMed ID: 23797796
    [No Abstract]   [Full Text] [Related]  

  • 13. Religious attendance: more cost-effective than lipitor?
    Denberg T
    J Am Board Fam Med; 2006; 19(4):430; author reply 431-3. PubMed ID: 16809663
    [No Abstract]   [Full Text] [Related]  

  • 14. Atorvastatin.
    Hyatt PJ
    Br J Hosp Med; 1997 Oct 1-14; 58(7):333-6. PubMed ID: 9509055
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV.
    Mah Ming JB; Gill MJ
    AIDS Patient Care STDS; 2003 May; 17(5):207-10. PubMed ID: 12816614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ritonavir and saquinavir combination therapy for the treatment of HIV infection.
    Cameron DW; Japour AJ; Xu Y; Hsu A; Mellors J; Farthing C; Cohen C; Poretz D; Markowitz M; Follansbee S; Angel JB; McMahon D; Ho D; Devanarayan V; Rode R; Salgo M; Kempf DJ; Granneman R; Leonard JM; Sun E
    AIDS; 1999 Feb; 13(2):213-24. PubMed ID: 10202827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid lowering therapy in patients with HIV infection.
    McBride M; Chin MT; Lee SM; Kelly B
    Lancet; 1998 Nov; 352(9142):1782-3. PubMed ID: 9848377
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperlipidemia associated with the use of protease inhibitors.
    Smith JH; Martin GJ; Decker CF
    Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432
    [No Abstract]   [Full Text] [Related]  

  • 19. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.
    Carr A; Samaras K; Burton S; Law M; Freund J; Chisholm DJ; Cooper DA
    AIDS; 1998 May; 12(7):F51-8. PubMed ID: 9619798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV protease inhibitors and dyslipidemia.
    Clotet B; Negredo E
    AIDS Rev; 2003; 5(1):19-24. PubMed ID: 12875104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.